With support from France Biotech and MabDesign, whose members will get a 50% discount off the ticket price by using a coupon code 50OFFPARTNERS.
Learn how your organization can sharpen its innovation culture and improve results by building innovation capabilities and unlocking untapped potential.
Learn about factors that make life science companies successful.
Design an innovation process contributing to the company’s growth and competitiveness. Transform to an agile, innovative organization through mindset and process.
Understand how your innovation capabilities will help to grow the business and how they compare with your industry peers.
| Time | Topic |
|---|---|
| 14:00 - 14:30 | Networking |
| 14:30 - 14:45 | Introduction: The Role of Innovation in Life Sciences |
| 14:45 - 15:30 | Agile Marketing and Business Organization to Improve the Company's Growth and Performance |
| 15:30 - 15:45 | Coffee Break |
| 15:45 - 16:30 | Innovation Lessons From +5,000 Companies in 105 Countries |
| 16:30 - 17:15 | Innovation Capabilities Based on InnoSurvey Results (Discussion in Groups) |
| 17:15 - 17:30 | Conclusions |
The major challenge of biotechnology companies that give access to technological platforms to accelerate new medicines is to continuously offer disruptive solutions with high technical and economic added value. To remain a leader, you must maintain a competitive advantage ensure revenue growth, and robust company performance. A well-established agile process is crucial to generate valuable solutions quickly.
Leading a transformation towards an agile organization is only possible by a pioneer team that has decided to make the revolution and has the ambition to thrive by proposing solutions that no one expects and continuously creating a better patient future. Some of these solutions include:
Speaker
Corporate visionary and executive leader in marketing and business with two decades of experience in the global biotech market. Driven to create value within biotech companies, providing access to technological platforms to support drug developers.
Oréda partners with innovative companies, such as Charles River, Taconic, Eurofins, Concept Life Science, Batavia Biosciences, Epivax, and startups that need to strengthen the management of the company’s growth and performance.
For many years, Oréda has been an external marketing and business expert at the CNRS Innovation and at the European Innovation Council, supporting company creation and start-ups. She obtained an executive Design Thinking and Agile Methods certificate at the ESSEC Business School and an Executive MBA. Before joining the industry, she spent ten years as a researcher at the Max Planck Institute and Gustave Roussy Institute, where she defended her Ph.D in 1996.
Speaker
Graduate of the Medical University in Wroclaw, Poland, Kasia has more than 30 years of leadership experience in the pharmaceutical, biotechnology, and medical device industries and oversaw the launches of several first-in-class brands, which profoundly improved the standards of patient care. She worked at Eli Lilly, Merck (MSD), Novartis, Sanofi, and Terumo BCT before focusing on medtech and digital tech startups as an advisor, mentor, and founder. She has deep experience developing enterprise, portfolio, and brand strategies, creating market conditions for growth through policy, advocacy, and scientific initiatives, and launching excellence. Recently, Kasia has been board-certified by the American Board of AI in Medicine.
As a consultant, Kasia helps healthcare and life science companies reach strategic goals through a robust innovation pipeline, build innovation capabilities, transform organizations, select the right strategic initiatives, including AI/ML solutions, and successfully commercialize them.
Despite enormous progress in the life science industry in the last decades, innovation management remains a struggle. InnoSurvey data from +5,000 companies show that only 10% can execute their strategy well, even though 78% make substantial efforts to innovate. The main reasons for this mismatch
are:
But innovation is a skill, and every company can master it through a more systematic approach. Let’s discuss how to evolve from a serendipitous event to a plannable outcome and the role of InnoSurvey® in measuring strengths and weaknesses to close the gap between aspiration and ability.
